Jill Ann Howe
Independent DirectorMs. Jill Ann Howe serves as Chief Financial Officer of Lineage Cell Therapeutics, Inc. since November 14, 2022 and serves as its Principal Financial and Accounting Officer since November 14, 2022. She served as Chief Financial Officer of DTx Pharma, Inc. since June 2021 until July 2022. She is an Independent Director at Biora Therapeutics, Inc. (formerly known as Progenity, Inc.) since November 3, 2021. She is Director of Codagenix, Inc. from October 2021. She has served as the Chief Financial Officer of DTx since June 2021, a role to which she brings experience in the biotechnology sector in operation and financial strategy, treasury, global infrastructure and compliance management. Prior to joining DTx, she was the Treasurer and Vice President of Finance at Gossamer Bio, Inc. from January 2018 to June 2021, where she was the internal project lead for the company's initial public offering, follow-on and debt offerings and oversaw finance for 18 subsidiaries across the U.S. and Ireland. she served as Controller of Amplyx Pharmaceuticals, Inc. a biopharmaceutical company, from 2016 to December 2017. She held Positions Including Controller and Director of Finance roles at Amplyx Pharmaceuticals, Receptos Inc. and Somaxon Pharmaceuticals. Ms. Howe received a Bachelor of Science in Accountancy from San Diego State University. She is a graduate of the Women in Bio Board Room Ready program.
Positions
- Company NameBiora Therapeutics, Inc.Stock CodeBIORQPositionIndependent DirectorColleagues
- APAditya P. MohantyCEO & Director
- JDJeffrey Donald AlterIndependent Chairman
- CNClarke NeumannSenior VP, General Counsel & Secretary
- KHKevin HoweSenior VP of Strategic Operations
- PSPaul ShabramHead of Technical Operations
- JKJames KnightHead of Business Development
- BLBrian L. KotzinIndependent Director
- BEBruce E. SandsChairman of Inflammatory Bowel Disease Clinical Advisory Board
- JAJill Ann HoweIndependent Director
- Company NameLineage Cell Therapeutics, Inc.Stock CodeLCTXPositionChief Financial OfficerColleagues
- BMBrian M. CulleyCEO, President & Director
- MHMichael H. MulroyIndependent Chairman
- GAGeorge A. SamuelGeneral Counsel & Company Secretary
- ICIoana C. HoneVP of Corporate Communications & Director of Investor Relations
- CHCharlotte HubbertVice President of Corporate Strategy & Development
- NCNeal Clifton BradsherIndependent Director
- DJDeborah J. AndrewsIndependent Director
- ACAngus C. RussellIndependent Director
